Evidence map›Paper›PMID 37494584›Full record

ReviewACS nano2023

Microrobots for Biomedicine: Unsolved Challenges and Opportunities for Translation.

Jin Gyun Lee, Ritu R Raj, Nicole B Day, C Wyatt Shields

Abstract readReview
In one paragraph

Review in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Embodied Cross-Domain Intelligence in Biomedical Microrobots: A Review.Cyborg and bionic systems (Washington, D.C.) · 2026
    Review
  13. Review
  14. Transport of Adoptive Cell Transfers With Magnetic Helical Microrobots.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Micro- and Nano-Bots for Infection Control.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  19. Treatment of lung diseasesMaterials today. Bio · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jin Gyun LeeDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.
Ritu R RajDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.
Nicole B DayDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.ORCID 0000-0003-1082-2887
C Wyatt ShieldsDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States.ORCID 0000-0003-4138-8462

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
Interdisciplinary Predoctoral Training in Molecular BiophysicsT32GM145437 · NIGMS · UNIVERSITY OF COLORADO · PI JOSEPH J FALKE · 2022 to 2026
$2.5M
Adoptive Macrophage Transfers for Nanoparticle DeliveryR35GM147455 · NIGMS · UNIVERSITY OF COLORADO · PI Charles Wyatt Shields IV · 2022 to 2026
$2.0M
NIGMS NIH HHS R35 GM147455NIGMS NIH HHS T32 GM065103NIGMS NIH HHS T32 GM145437
6 · The paper itself

Abstract

Microrobots are being explored for biomedical applications, such as drug delivery, biological cargo transport, and minimally invasive surgery. However, current efforts largely focus on proof-of-concept studies with nontranslatable materials through a "

Indexed as

RoboticsBiocompatible MaterialsDrug Delivery SystemsHumansMinimally Invasive Surgical ProceduresBiocompatible Materials

Identifiers

PMID37494584
PMCPMC10928690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.